| Financial Year |
March 31 2023 |
| Monetary Funds |
304,059,586.08 |
| Held-for-trading Financial Assets |
560,260.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
158,283,085.64 |
| Advances to Suppliers |
18,842,507.06 |
| Other Receivables |
13,243,093.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
174,489,024.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,706,211.89 |
| Total Current Assets |
678,183,768.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,555,047.05 |
| Investment Properties |
63,539,558.69 |
| Fixed Assetes |
391,169,719.95 |
| Under-construction Projects |
3,100,132.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,897,499.11 |
| R&D expenses |
-- |
| Goodwill |
28,548,569.73 |
| Long-Term Deferred and Prepaid Expenses |
7,645,589.33 |
| Deferred Income Tax Assets |
15,641,927.38 |
| Other Non-Current Assets |
2,020,367.61 |
| Sub-Total of Non-Current Assets |
634,808,909.05 |
| Total Assets |
1,312,992,677.86 |
| Short-Term Loans |
68,021,529.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,780,000.00 |
| Accounts Payable |
106,555,516.54 |
| Accounts Received In Advance |
6,414.74 |
| Employee Compensation Payable |
27,319,638.71 |
| Taxes Payable |
5,984,449.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,885,606.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
162,277,080.33 |
| Other Current Liabilities |
69,795.07 |
| Sub-Total of Current Liabilities |
394,976,361.48 |
| Long-term Loans |
101,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,430,197.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
133,418,749.86 |
| Total Liabilities |
528,395,111.34 |
| Paid-In Capital(Or Share Stock) |
181,999,640.00 |
| Capital Surplus |
299,971,915.94 |
| Surplus Reserve |
52,747,824.75 |
| LESS:Treasury Stock |
18,333,718.66 |
| Undistributed Profits |
246,395,836.20 |
| Minority Stockholder's Interest |
30,784,881.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
753,812,685.12 |
| Owner's Equity（Stockholder's Equity） |
784,597,566.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,312,992,677.86 |
